MADISON, Wis., Aug. 11, 2021 /PRNewswire/ -- Mirus Bio, an innovator in transfection technologies, today announces the launch of the TransIT® VirusGEN® GMP product line. This expansion to the existing ...
Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement company’s upstream ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix SA, a technology innovation company focused on addressing gene and cell therapy manufacturing gaps, announced today the launch of NBX-HEK293, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback